Cubist Systematic Strategies, LLC Johnson & Johnson Call Options Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $12 Million - $13.2 Million	-83,400 Reduced 78.53%	22,800 $3.33 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $7 Million - $7.34 Million	-45,100 Reduced 29.81%	106,200 $16.8 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $1.53 Million - $1.67 Million	10,500 Added 7.46%	151,300 $23.7 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $8.43 Million - $9.44 Million	54,100 Added 62.4%	140,800 $21.9 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $4.31 Million - $4.63 Million	-27,900 Reduced 24.35%	86,700 $14.4 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $3.67 Million - $4.38 Million	-24,300 Reduced 17.49%	114,600 $17.8 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $80,100 - $89,895	-500 Reduced 0.36%	138,900 $24.5 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $4.18 Million - $4.65 Million	25,900 Added 22.82%	139,400 $22.8 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $19.1 Million - $21.1 Million	113,500 New	113,500 $20.1 Million

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.